C
TXG icon

Certuity’s 10x Genomics TXG Stock Holding History

Certuity’s Portfolio TXG Stock Details TXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.01M Sell
26,281
-4,625
-15% -$121K 0.05% 177
2026
Q1 		$656K Buy
30,906
+10,702
+53% +$214K 0.04% 231
2025
Q4 		$330K Buy
20,204
+904
+5% +$13.7K 0.02% 386
2025
Q3 		$226K Buy
+19,300
New +$252K 0.02% 491

Other funds holding TXG

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
QCM
Quantinno Capital Management New York $83.3B AUM 37.97% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Certuity's TXG Position: Q2 2026 in Review

Certuity reduced its 10x Genomics (TXG) stake by 15% in Q2 2026, selling an estimated $121K and leaving 26,281 shares worth $1.01M. The position accounts for 0.05% of the portfolio, ranked #177.

Certuity first reported a position in TXG in Q3 2025 and has held it in 4 quarters since. 392 funds tracked by Wall St. Rank hold TXG as of Q2 2026.

  • Certuity held 26,281 shares of 10x Genomics worth $1.01M as of Q2 2026.
  • Certuity sold 4,625 10x Genomics shares in Q2 2026, an estimated $121K.
  • 10x Genomics made up 0.05% of Certuity's portfolio in Q2 2026, its #177 holding.
  • Certuity first reported a position in 10x Genomics in Q3 2025 and has held it in 4 quarters since.
  • 392 funds tracked by Wall St. Rank held 10x Genomics as of Q2 2026.

Based on Certuity's 13F filing for Q2 2026, filed 28 Jul 2026.